Literature DB >> 8609395

Antigen presentation by T cells inhibits IL-2 production and induces IL-4 release due to altered cognate signals.

G Lombardi1, R Hargreaves, S Sidhu, N Imami, L Lightstone, S Fuller-Espie, M Ritter, P Robinson, A Tarnok, R Lechler.   

Abstract

Conflicting results of the effects of Ag presentation by MHC class II-expressing T cells have been described. In some studies class II-expressing T cells have been shown to act as effective APCs, while others have reported that the recognition of Ag on the surface of another T cell inactivates IL-2 production. In this study we have investigated the mechanisms involved in Ag presentation by T cells. The results obtained suggest that 1) lack of costimulation is not responsible for the inhibitory effects of T cell Ag presentation on IL-2 production; the provision of costimulation by immobilized anti-CD28 Ab or by the addition of accessory cells failed to reverse the effects of T cell Ag presentation, but restored the response to immobilized anti-CD3; 2) T cell Ag presentation induced a minimal increase in intracellular Ca2+ compared with that induced by antigen-pulsed B cells; this difference in the calcium response is not explained by quantitative differences in ligand density between B cells and T cells; and 3) despite the weak calcium signal, T cell presentation supported IL-4 release in the absence of IL-2 production. Taken together these data suggest that T cell Ag presentation leads to altered TCR/CD3-transduced signals, which biases the T cell towards a Th2 phenotype.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609395

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  The contributions of T-cell anergy to peripheral T-cell tolerance.

Authors:  R Lechler; J G Chai; F Marelli-Berg; G Lombardi
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 3.  The peripheral generation of CD4+ CD25+ regulatory T cells.

Authors:  Arne N Akbar; Leonie S Taams; Mike Salmon; Milica Vukmanovic-Stejic
Journal:  Immunology       Date:  2003-07       Impact factor: 7.397

4.  T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro.

Authors:  P G Steenbakkers; A M Boots; A W Rijnders
Journal:  Immunology       Date:  1999-04       Impact factor: 7.397

5.  Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S M Cruickshank; J Southgate; J I Wyatt; P J Selby; L K Trejdosiewicz
Journal:  J Clin Pathol       Date:  1999-10       Impact factor: 3.411

6.  Identification of the neoplastically transformed cells in Marek's disease herpesvirus-induced lymphomas: recognition by the monoclonal antibody AV37.

Authors:  Shane C Burgess; T Fred Davison
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy.

Authors:  A Pires; M Nelson; A L Pozniak; M Fisher; B Gazzard; F Gotch; N Imami
Journal:  J Immune Based Ther Vaccines       Date:  2005-09-25

8.  A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy.

Authors:  Gareth Ad Hardy; Nesrina Imami; Mark R Nelson; Ann K Sullivan; Ron Moss; Marlén Mi Aasa-Chapman; Brian Gazzard; Frances M Gotch
Journal:  J Immune Based Ther Vaccines       Date:  2007-04-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.